Most cited papers from Galderma (United States)

Galderma (United States)

What are the most cited papers from Galderma (United States)?

The most cited paper from Galderma (United States) is "Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method" (Amit G. Pandya, Linda Susan Hynan, Rafia Bhore et al., 2010), with 332 citations. Next come "Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis" (281) and "Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus" (275).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 23 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method Amit G. Pandya, Linda Susan Hynan, Rafia Bhore et al. · Journal of the American Academy of Dermatology Open access	16 Apr 2010	332
2	Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis Sonja Ständer, Gil Yosipovitch, Franz Josef Legat et al. · New England Journal of Medicine Open access	19 Feb 2020	281
3	Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus Jonathan I. Silverberg, Andreas Pinter, Grażyna Pulka et al. · Journal of Allergy and Clinical Immunology Open access	23 Aug 2019	275
4	Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis Shawn G. Kwatra et al. · New England Journal of Medicine Open access	25 Oct 2023	189
5	A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial Alan R. Shalita, Jonathan Weiss, Dan K. Chalker et al. · Journal of the American Academy of Dermatology	Mar 1996	187
6	Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics Anna Holmes, Martin S. Steinhoff · Experimental Dermatology	4 Jul 2016	186
7	The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products Matthew Meckfessel, Staci Brandt · Journal of the American Academy of Dermatology	21 Mar 2014	185
8	Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study Diane M. Thiboutot, Jonathan Weiss, Alicia D. Bucko et al. · Journal of the American Academy of Dermatology	27 Jul 2007	183
9	Rheologic and Physicochemical Properties Used to Differentiate Injectable Hyaluronic Acid Filler Products Steven Fagien, Vince Bertucci, Erika von Grote et al. · Plastic & Reconstructive Surgery Open access	28 Mar 2019	178
10	Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies Joseph F. Fowler, Michael Jarratt, Angela Yen Moore et al. · British Journal of Dermatology Open access	2 Nov 2011	168
11	Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials Jonathan I. Silverberg et al. · The Lancet	24 Jul 2024	156
12	Potential role of microorganisms in the pathogenesis of rosacea Anna Holmes · Journal of the American Academy of Dermatology	5 Sep 2013	152
13	Evidence-based update on rosacea comorbidities and their common physiologic pathways Anna Holmes, Julia Spoendlin, Anna Lien-Lun Chien et al. · Journal of the American Academy of Dermatology	28 Oct 2017	143
14	Reliability of Clinician Erythema Assessment grading scale Jerry K.L. Tan, Hong Liu, James J. Leyden et al. · Journal of the American Academy of Dermatology	3 Jul 2014	140
15	Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients Harald P. M. Gollnick, Zoe Diana Draelos, Martha Jane Glenn et al. · British Journal of Dermatology	11 Apr 2009	128
16	Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne Jerry K.L. Tan, Diane M. Thiboutot, Georg Popp et al. · Journal of the American Academy of Dermatology Open access	22 Feb 2019	123
17	Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study John E. Wolf, David Lee Kaplan, Stephen J. Kraus et al. · Journal of the American Academy of Dermatology	Sep 2003	105
18	Novel retinoid-related molecules as apoptosis inducers and effectve inhibitors of human lung cancer cells in vivo Xianping Lu, Andrea N. Fanjul, Nathalie Picard et al. · Nature Medicine	Jun 1997	87
19	Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR ‐γ selective topical retinoid, in patients with moderate facial and truncal acne Ulrike Blume‐Peytavi, Joseph F. Fowler, Lajos V. Kemény et al. · Journal of the European Academy of Dermatology and Venereology Open access	15 Jul 2019	86
20	Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne J. Czernielewski, Sylvie Michel, Martine Bouclier et al. · Journal of the European Academy of Dermatology and Venereology	Dec 2001	83
21	Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea Mark V. Dahl, Michael Jarratt, David Lee Kaplan et al. · Journal of the American Academy of Dermatology	Nov 2001	77
22	How People with Facial Acne Scars are Perceived in Society: an Online Survey Brigitte Dréno, Jerry K.L. Tan, Sewon Kang et al. · Dermatology and Therapy Open access	18 Apr 2016	73
23	Combination Therapy With Adapalene Gel 0.1% and Doxycycline for Severe Acne Vulgaris: A Multicenter, Investigator‐Blind, Randomized, Controlled Study Thiboutot Diane M., Shalita Alan R., Yamauchi Paul S. et al. · SKINmed Dermatology for the Clinician Open access	May 2005	71
24	A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Linda Stein Gold, Jerry K.L. Tan, Alma M. Cruz-Santana et al. · PubMed	Aug 2009	69
25	Comparative tolerance of adapalene 0·1% gel and six different tretinoin formulations Galvin, Gilbert, B I Baker et al. · British Journal of Dermatology	Sep 1998	67
26	Comparison of adapalene 0·1% solution and tretinoin 0·025% gel in the topical treatment of acne vulgaris Charles N. Ellis, Millikan, Smith et al. · British Journal of Dermatology	Sep 1998	63
27	Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis Sonja Ständer et al. · JAMA Dermatology Open access101 authors	27 Nov 2024	61
28	Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study Linda Stein Gold, Jonathan Weiss, María José Rueda et al. · American Journal of Clinical Dermatology Open access	5 Mar 2016	61
29	Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life. Tu T Huynh · PubMed Open access	Jul 2013	61
30	Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study Jonathan I. Silverberg, Andreas Pinter, Afsáneh Alavi et al. · Journal of the European Academy of Dermatology and Venereology Open access	12 Mar 2021	59
31	Sequential Treatment with Triple Combination Cream and Intense Pulsed Light is More Efficacious than Sequential Treatment with an Inactive (Control) Cream and Intense Pulsed Light in Patients with Moderate to Severe Melasma Mitchel P. Goldman, Michael H. Gold, Melanie D. Palm et al. · Dermatologic Surgery	26 Jan 2011	57
32	Effects of a low-potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis Jon M. Hanifin, Adelaide Ann Hebert, Steven R. Mays et al. · Current Therapeutic Research	Apr 1998	56
33	Adapalene 0·1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0·025% cream in skin tolerance and patient preference Dunlap, Mills, Tuley et al. · British Journal of Dermatology	Sep 1998	56
34	Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: A randomized comparison of efficacy and safety in subjects with scalp psoriasis Pascal Reygagne, Ulrich Mrowietz, Jacques Decroix et al. · Journal of Dermatological Treatment	Feb 2005	54
35	Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances Sonja Ständer, Gil Yosipovitch, J.‐P. Lacour et al. · Journal of the European Academy of Dermatology and Venereology Open access	29 Jun 2022	50
36	Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma Pearl E. Grimes, Jag Bhawan, Ian L. Guevara et al. · Journal of the American Academy of Dermatology	16 Apr 2010	48
37	Evaluation of Rheometry Amplitude Sweep Cross-Over Point as an Index of Flexibility for HA Fillers Åke Öhrlund · Journal of Cosmetics Dermatological Sciences and Applications Open access	2018	45
38	Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial Anna Di Nardo, Anna Holmes, Yumiko Muto et al. · Journal of the American Academy of Dermatology	5 Mar 2016	44
39	A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris Brad A. Yentzer, Amy L. Gosnell, Adele R. Clark et al. · Journal of the American Academy of Dermatology Open access	17 Mar 2011	41
40	Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel Catherine Queille‐Roussel, Michel Poncet, Stephane Mesaros et al. · Clinical Therapeutics	Feb 2001	40
41	Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents Robert Sidbury, Sady Alpizar, Vivian T. Laquer et al. · Dermatology and Therapy Open access	28 Jan 2022	38
42	Dynamics of hyaluronic acid fillers formulated to maintain natural facial expression Nowell J. Solish, Vince Bertucci, Ivona Percec et al. · Journal of Cosmetic Dermatology Open access	29 Apr 2019	37
43	Topical Retinoids Michèle Verschoore, Martine Bouclier, J. Czernielewski et al. · Dermatologic Clinics	1993	36
44	Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients Joseph Lucius Jorizzo, Moise L. Levy, Anne W. Lucky et al. · Journal of the American Academy of Dermatology	Jul 1995	34
45	Clinical Pharmacology and Safety of Trifarotene, a First‐in‐Class RARγ‐Selective Topical Retinoid Nathalie Wagner, Khaled Benkali, Alessandra Alió Sáenz et al. · The Journal of Clinical Pharmacology Open access	3 Feb 2020	33
46	A daily skincare regimen with a unique ceramide and filaggrin formulation rapidly improves chronic xerosis, pruritus, and quality of life in older adults Anne Lynn S. Chang, Suephy C. Chen, Lars Osterberg et al. · Geriatric Nursing	7 Jun 2017	33
47	Safety and Tolerability of a Body Wash and Moisturizer When Applied to Infants and Toddlers with a History of Atopic Dermatitis: Results from an Open‐Label Study Eric Lawrence Simpson, Nathan S. Trookman, Ronald L. Rizer et al. · Pediatric Dermatology	8 Jul 2012	33
48	Effectiveness and Safety of Large Gel Particle Hyaluronic Acid With Lidocaine for Correction of Midface Volume Deficit or Contour Deficiency Robert A. Weiss, Amir Moradi, David E. Bank et al. · Dermatologic Surgery	13 May 2016	32
49	Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study Stephen Matthew Schleicher, Angela Yen Moore, Elyse S. Rafal et al. · Dermatology and Therapy Open access	15 Oct 2023	30
50	Effectiveness and Safety of Sculptra Poly-L-Lactic Acid Injectable Implant in the Correction of Cheek Wrinkles Sabrina Guillen Fabi, Tiffani K. Hamilton, Brenda LaTowsky et al. · Journal of Drugs in Dermatology Open access	Dec 2023	29

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.